IMLT21110 // KT-US-982-5968 // Reagan
Basic Study Information
Purpose:
The goal of this clinical study is to learn more about the long-term safety, effectiveness
and prolonged action of Kite study drugs, axicabtagene ciloleucel, brexucabtagene
autoleucel, KITE-222, KITE-363, KITE-439, KITE-585, and KITE-718, in participants
of Kite-sponsored interventional studies.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Patrick Reagan
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search